Elgebli Ali, Hall Jason, Phipps Denham L
Division of Pharmacy & Optometry, Faculty of Biology, Medicine & Health, The University of Manchester, Stopford Building, Room 1.183, Oxford Road, Manchester M13 9PT, United Kingdom.
Explor Res Clin Soc Pharm. 2025 Jan 21;17:100569. doi: 10.1016/j.rcsop.2025.100569. eCollection 2025 Mar.
Community pharmacists (CPs) make a significant number of decisions on the clinical appropriateness of prescriptions daily to ensure safe and effective use of medications, in a process known as "clinical checking". The process is complex and is affected by multiple factors in practice. This study aimed to investigate the cognitive processes involved in clinical prescription checking by CPs.
This qualitative study employed a purposive sampling technique to recruit a diverse sample from the population of CPs in England. Engaging in Zoom interviews, participants clinically checked three simulated prescriptions, providing concurrent verbal accounts of their thoughts. The participants' commentaries during the task were audio-recorded, transcribed verbatim, and underwent deductive thematic analysis based on Klein's recognition-primed decision-making (RPD) model.
Twelve CPs from diverse backgrounds and varied working conditions were recruited and completed the online checking task. Making decisions on the clinical appropriateness of prescriptions appeared to be a multi-staged procedure whereby several levels of concerns exist, and pharmacists vary in their ability to recognise and resolve those concerns. CPs behaved in a manner similar to that described by the RPD model; they mostly engaged in pattern-recognition during clinical checking, but adopted a more analytical approach when they recognised an atypical situation. Participants showed more consistency when processing cues and expectancies; however, their subsequent actions exhibited substantial variability, coupled with a degree of hesitancy.
Clinical checking of prescriptions is a multifaceted process in which pharmacists employ a blend of pattern recognition and analytical thinking when making decisions. The process differs notably among pharmacists, underscoring the need to understand the factors driving these variations and any hesitancy in decision- making, as well as their potential impact on patient safety.
社区药剂师(CPs)每天都会对处方的临床适宜性做出大量决策,以确保药物的安全有效使用,这一过程被称为“临床检查”。该过程很复杂,在实际操作中会受到多种因素的影响。本研究旨在调查社区药剂师在临床处方检查中所涉及的认知过程。
这项定性研究采用了目的抽样技术,从英格兰的社区药剂师群体中招募了一个多样化的样本。通过Zoom访谈,参与者对三份模拟处方进行临床检查,并同时口头阐述他们的想法。任务过程中参与者的评论被录音、逐字转录,并根据克莱因的基于识别启动的决策(RPD)模型进行了演绎主题分析。
招募了12名来自不同背景和工作条件的社区药剂师,他们完成了在线检查任务。对处方的临床适宜性做出决策似乎是一个多阶段的过程,存在多个层面的关注点,并且药剂师识别和解决这些关注点的能力各不相同。社区药剂师的行为方式与RPD模型所描述的相似;他们在临床检查过程中大多进行模式识别,但在识别到非典型情况时会采用更具分析性的方法。参与者在处理线索和预期时表现出更高的一致性;然而,他们随后的行动表现出很大的变异性,同时伴有一定程度的犹豫。
处方的临床检查是一个多方面的过程,药剂师在做出决策时会综合运用模式识别和分析性思维。药剂师之间的这个过程存在显著差异,这突出了理解驱动这些差异以及决策过程中任何犹豫的因素的必要性,以及它们对患者安全的潜在影响。